Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary comput... Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to leading pharmaceutical and biotechnology companies. Mehr anzeigen
- In Phase 2a arm investigating IMM-1-104 in combination with modified gemcitabine/nab-paclitaxel, complete or partial responses have been observed in the first two patients (2/5) to date, for an...
CAMBRIDGE, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for...
- Enrollment progressing well across all arms in the IMM-1-104 Phase 2a Trial, with Initial Data from Multiple Arms Expected in 2H 2024 - - Granted FDA Fast Track Designation for IMM-1-104 in...
- IMM-1-104 Fast Track designation now granted for the treatment of both first and second-line pancreatic ductal adenocarcinoma (PDAC); provides potential to accelerate IMM-1-104’s path to U.S...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1016 | -4.41585535466 | 2.3008 | 2.7 | 2.11 | 696391 | 2.43176018 | CS |
| 4 | 1.0192 | 86.3728813559 | 1.18 | 3.83 | 1.18 | 14942194 | 2.42995317 | CS |
| 12 | 0.9892 | 81.7520661157 | 1.21 | 3.83 | 1 | 6635392 | 2.1627822 | CS |
| 26 | 0.0792 | 3.7358490566 | 2.12 | 3.83 | 1 | 3260202 | 2.12969583 | CS |
| 52 | -5.0408 | -69.6243093923 | 7.24 | 8.89 | 1 | 1810363 | 2.22921582 | CS |
| 156 | -25.8108 | -92.1485183863 | 28.01 | 31.885 | 1 | 661759 | 2.83843082 | CS |
| 260 | 2.1468 | 4096.94656489 | 0.0524 | 33.99 | 0.0524 | 500316 | 3.18233288 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
